A study has cast doubt on the widely cited claim that antidepressant drugs such as SSRIs have few withdrawal symptoms, revealing that pharmaceutical industry funding could be skewing data to minimise adverse effects. This story first appeared on leafie, view here Author: Liam O'Dowd
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year, with a focus on bridging the gap between policy and patient access. The one-day, CPD-accredited Cannabis Health Symposium, taking place at Conway Hall in London on Tuesday 25 November, 2025, is [...]
Despite a slow start in facilitating patient access to medical cannabis treatments, this is gradually changing for the better. The UK now has an active patient base of approximately 50,000-60,000, and an estimated 80,000 individuals are expected to receive treatment with CBPMs throughout 2025. The CQC [...]
Cannabis isn’t the “gateway drug” many opponents have labelled it; it’s a plant that leads people into growing their own fruits and vegetables at home. This story first appeared on leafie, view here Author: Kevin Dinneen
Scientists in South Africa say they have found the first evidence of a rare class of phenolics, called ‘flavoalkaloids’, in leaves from the cannabis plant. Phenolic compounds, especially flavonoids, are well-known and sought after in the pharmaceutical industry because of their antioxidant, anti-inflammatory, and anti-carcinogenic properties. [...]
The Minister for Policing and Crime Prevention, Dame Diana Johnson MP, has agreed to ban HHC and other semi-synthetic cannabinoids following AMCD recommendations, which also recommended that THCa be banned. This story first appeared on leafie, view here Author: Liam O'Dowd
A new review has found ‘consistent evidence’ that cannabis improves sexual function in women, and should be considered as a first-line treatment for patients with female orgasm disorder (FOD). After reviewing findings from 16 peer-reviewed studies, including data from over 8,000 women, researchers have formally recommended [...]
A UK medical cannabis clinic is carrying out investigations after a substantial amount of patients’ information was leaked in a major data breach. In an email sent to patients on Monday 18 August, CB1 Medical confirmed it had identified a ‘data security incident’ when patients’ personal [...]
PatientsCann UK has raised urgent concerns with both the UK and Republic of Ireland (ROI) governments over the risks faced by patients prescribed medicines that are classified as Schedule 1 Controlled Drugs in one jurisdiction but legally prescribed in the other. At present, a prescription issued in the UK, ROI or Crown Dependencies cannot be dispensed across the border if the medicine is considered Schedule 1. More critically, patients cannot lawfully carry these prescribed medicines across the border, even if the crossing is unavoidable in order to travel within their own country. This issue disproportionately affects border communities, where travel across the border is not optional but a daily necessity. For patients in these communities, this creates an impossible situation: return home with their prescribed treatment and risk criminalisation, or forego essential medication. Couriers and healthcare professionals delivering medicines face the same challenge. Practical problems and risks The current situation gives rise to multiple, connected harms: Beyond individual harm, the problem creates wider public-health and administrative issues: increased emergency presentations, greater strain on social care and inequitable access to treatment depending on postcode. What PatientsCann UK is asking for PatientsCann UK has written to the governments of the UK and the Republic of Ireland requesting urgent clarification and guidance, including: The Northern Ireland Office has confirmed that officials are reviewing our letter. PatientsCann UK welcomes this development and will continue to press for clear, rapid action to protect patients who rely on any prescribed medicine. Sal Aziz, Director of PatientsCann UK, said: “Patients should never have to choose between taking their prescribed medicine and risking criminalisation. In practice this is what border communities on the island of Ireland face today. Governments must issue clear operational guidance and protections, urgently, so patients can continue to receive care without fear.” What happens next PatientsCann UK will publish updates as official responses are received. In the meantime, anyone affected by this issue is encouraged to contact PatientsCann UK so we can collate evidence and ensure our representations fully reflect the scale and immediacy of the problem. Please email info@patientscann.org.uk or send us a message on socials (Instagram | X).
The post Border Patients at Risk: PatientsCann Raises Concerns with UK & Ireland first appeared on PatientsCann UK.
Using a unique method of analysis, a team of researchers found a number of rare compounds called flavoalkaloids in cannabis leaves for the first time, suggesting that plant material traditionally discarded during processing could contain valuable compounds for future medical applications. This story first appeared on [...]
A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues such as chronic pain and women’s health-related concerns. Out of 500 doctors currently practicing in the NHS, almost half of which were GPs, three quarters said that [...]
Ireland has become the latest jurisdiction to ban the use of the semi-synthetic cannabinoid HHC, with ministers raising concerns related to growing use among young people and risks to mental health. The decision, announced by the Department of Health on 29 July, sees Hexahydrocannabinol (HHC) classified as [...]
Study of over 25,000 people found that people who used cannabis performed better in cognitive tests than non users. This story first appeared on leafie, view here Author: Liam O'Dowd
New research on a large data set of older adults suggests cannabis use may be linked to slower brain ageing and improved cognitive function. The study, which used data collected from 25,000 adults aged between 44 and 81 years, found that those who had consumed cannabis [...]
The Advisory Council on the Misuse of Drugs recommended easing the rules on researching substances such as LSD and MDMA, and the government have responded favourably This story first appeared on leafie, view here Author: Kevin Dinneen
A new study is the first to confirm a link between an invasive fungal infection and a medical cannabis product sold to a patient in the US. A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after [...]
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot scheme for inspiration, COVID-19, waning political will, operational hurdles, and the dissolution of the National Assembly [...]
A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with cannabis use disorder (CUD) are more than three times more likely to develop oral cancer within five years compared to those without CUD. In 2022, 17.7 [...]
The Care Quality Commission has raised a number of concerns related to the prescribing of cannabis-based products for medicinal use in the UK, as the latest data reveals further increases in private prescriptions. Earlier this month the independent regulator which is responsible for overseeing health and [...]
Demand for private cannabis prescriptions is expected to double in the next four years as patient numbers in Europe’s 2nd largest medical market continue to rise. This story first appeared on leafie, view here Author: Kevin Dinneen
An international survey of people living with eating disorders has found that cannabis and psychedelics, such as ‘magic mushrooms’ or LSD, were best rated as alleviating symptoms by respondents who self-medicated with the non-prescribed drugs. The worst-rated drugs were alcohol, tobacco, nicotine and cocaine. Meanwhile, prescribed [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
